Felvizumab

Cat. No. M24783

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

SB 209763; RSHZ19

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.

Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the F glycoprotein of RSV.

CAS Number	167747-20-8
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

Related RSV Products
Ribavirin Ribavirin (ICN-1229) is an antiviral agent used to study severe RSV infections, hepatitis C virus infections, and other viral infections.
Presatovir Presatovir is a novel, orally bioavailable RSV fusion inhibitor, against a wide range of RSV A and B clinical isolates (mean EC50 = 0.43 nM).
RSV604 (A-60444) RSV604 (A-60444) is a cell-permeable, non-cytotoxic (CC50 >50 μM) benzodiazepine derivative that is reported to target respiratory syncytial virus (RSV) nucleoprotein (N), with a Kd of 1.6 μM. RSV604 displays submicromolar activity against numerous clinical isolates of both the A and B subtypes of RSV (average EC50s=0.8 μM).
VV116 hydrobromide VV116 (JT001) hydrobromide is an orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV) infection.
Palivizumab Palivizumab (MEDI 493) is a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection.

Catalog